More from Sakir saiyed
The poll saw highest interest in Agro-chemicals.
— Multipie (@MultipieSocial) June 25, 2021
So today we visualize the 10 year change in market cap of key agrochem and fertilizer companies. #MultipieVisuals
Which one do you like? pic.twitter.com/sNMzmEXCJz
#deepaknitrite
MOSL initiates on Deepak Nitrite pic.twitter.com/vkfW47qraT
— Darshan Mehta (@darshanvmehta1) June 30, 2021
#deepaknitrite
Deepak Nitrite was ignored at 250, 400, 600, 800, 1200, 1600 and now at 1800.
— LearnLifeWealthTravel | Dream Big, Think Growth !! (@AnyBodyCanFly) June 30, 2021
Review why you ignored this and other such names in past.... If you understand this well, you may correct your ignorance atleast as of today.#investing #BePositive
#DeepakNitrite
#DeepakNitrite valuation is most attractive in the space...
— jeevan patwa (@jeevanpatwa) June 30, 2021
growth will be most explosive in the space... pic.twitter.com/8VYdWwFApY
#deepaknitrite
#deepaknitrite stands out well against all this chem pack in valuations \U0001f447
— Sakir saiyed (@sakir_saiyed_) June 30, 2021
ROE : 39
ROCE : 40
P/S : 5.5
Quality management 5/5 \U0001f44f\U0001f44f pic.twitter.com/ubSvUri4KL
More from Saregama
Double Top Buy & T20 Pattern - Bullish triggered above 3596.76 daily close on 3% Box Size chart. https://t.co/130vDnOAzm
SAREGAMA
— Saket Reddy (@saketreddy) July 15, 2021
Double Top Buy & T20 Pattern - Bullish above 3601.56 daily close on 1% Box Size chart. https://t.co/3514cyjgDH pic.twitter.com/pdlyX1pdre
Saregama - Simple MA strategy working well. A price constantly testing 20 EMA and bouncing back is the one that is in a strong uptrend. If you miss any one of the strongest stocks during a breakout, observe its reaction as it comes near 20 EMA again and hunt it down.
Saregama - \U0001f3b9\U0001f3b6\U0001f3bc\U0001f3b5
— Steve Nison (@nison_steve) July 14, 2021
Will it respect the 20 EMA again? So far, no serious selling. Price coming down with negligible volumes. pic.twitter.com/CEB6OTJssd
Chart attached
How Beautifully Price is giving respect to Trendline. https://t.co/55F37IKfKG
Time & Price Correction Came
— Market Learner \U0001f3af (@MarketLearner7) July 30, 2021
Taking supports as per mentioned levels &
Ready to bounce back
Multi-Bagger Giving Opportunity
Now its time to show execution power #LaurusLab #Saregama@jainchintan67 @RajarshitaS @ca_mehtaravi @nid_rockz https://t.co/95N2zTOCfr pic.twitter.com/jzhipRyBVs
You May Also Like
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj
@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
Alain Merieux, who owns bioMerieux, was instrumental in the creation of the Wuhan Institute of Virology P4 Lab.
The same people who helped create the virus, also helped to create the vaccines...
Moderna partnered with French Pasteur Institute in 2015 to develop mRNA vaccine technology.
Pasteur Institute partnered with the Wuhan P4 Laboratory in 2017 along with the Merieux Foundation to study emerging viruses...
https://t.co/yFsHwrNYaK
https://t.co/9M5lydBKhM
Nobel prize winning scientist Luc Montagnier asserts that Sars-Cov-2 is man-made and originated from the Wuhan Institute of Virology.
Montagnier did extensive work with the Pasteur Institute in France which was partnered with the Wuhan P4.
Merieux Foundation & the Chinese government have worked together since 1965, and partnered to study emerging pathogens in Africa in 2015.
Their research included "PATHOGENS CARRIED BY BATS" that provoke respiratory diseases.
🚨🚨🚨
https://t.co/gVwpT0ssqI